牛皮PSORI-CM01的分子机制通过调节炎性细胞因子网络来调节牛皮
Mingxiang Xie1, Miaomiao Zhang2, Yuanyuan Qiao3
1Research Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China; Central Laboratory, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, 510910, China.
Journal of ethnopharmacology
|July 21, 2023
概括
这项研究揭示,因西林优化配方 (PSORI-CM01) 通过通过PI3K-Akt信号通路调节炎症因素来治疗牛皮. 这些发现提供了对传统中医药治疗牛皮的分子机制的见解.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,缺乏确定的治疗方法.
- 传统中国医学 (TCM) 提供了多种治疗牛皮的方法,其中Yinxieling优化公式 (PSORI-CM01) 显示了临床疗效.
- 基于PSORI-CM01治疗效果的精确分子机制在很大程度上仍未被阐明.
研究的目的:
- 为了阐明PSORI-CM01在治疗牛皮中的分子机制.
- 确定PSORI-CM01.01针对的关键活性化合物和信号通路.
主要方法:
- 系统药理学被用来预测活性化合物和信号通路.
- MTT测定选了活性化合物并评估了它们的综合作用.
- 人类Th17磁珠面板和qRT-PCR分析了炎症因子和关键途径标的调节.
主要成果:
- 在PSORI-CM01中确定了26种潜在活性化合物,包括酸和液基因因.
- 在活性化合物之间观察到协同作用和对抗作用的相互作用.
- PSORI-CM01调节了各种炎症性细胞因子,主要向PI3K-Akt信号通路.
结论:
- 通过调节炎症因子网络,PSORI-CM01对牛皮产生治疗作用.
- 确定PI3K-Akt信号通路是PSORI-CM01作用的关键调解器.
- 这项研究为PSORI-CM01在牛皮管理中的使用提供了分子基础.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
174
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
174


